HomeCompareMYOV vs VICI

MYOV vs VICI: Dividend Comparison 2026

MYOV yields 7.41% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $933.6K in total portfolio value· pulled ahead in Year 2
10 years
MYOV
MYOV
● Live price
7.41%
Share price
$26.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.7K
Annual income
$1,186.18
Full MYOV calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — MYOV vs VICI

📍 VICI pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMYOVVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MYOV + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MYOV pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYOV
Annual income on $10K today (after 15% tax)
$630.10/yr
After 10yr DRIP, annual income (after tax)
$1,008.25/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $515,261.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYOV + VICI for your $10,000?

MYOV: 50%VICI: 50%
100% VICI50/50100% MYOV
Portfolio after 10yr
$499.4K
Annual income
$304,281.15/yr
Blended yield
60.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

MYOV
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-3.0
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYOV buys
0
VICI buys
0
No recent congressional trades found for MYOV or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMYOVVICI
Forward yield7.41%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$32.7K$966.2K
Annual income after 10y$1,186.18$607,376.13
Total dividends collected$9.7K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: MYOV vs VICI ($10,000, DRIP)

YearMYOV PortfolioMYOV Income/yrVICI PortfolioVICI Income/yrGap
1$11,441$741.29$11,361$941.49+$80.00MYOV
2← crossover$13,035$792.65$13,320$1,481.32$285.00VICI
3$14,791$843.97$16,284$2,405.01$1.5KVICI
4$16,722$895.04$21,040$4,071.78$4.3KVICI
5$18,838$945.65$29,209$7,285.49$10.4KVICI
6$21,152$995.63$44,443$14,006.51$23.3KVICI
7$23,678$1,044.81$75,822$29,512.55$52.1KVICI
8$26,428$1,093.05$148,733$69,726.75$122.3KVICI
9$29,418$1,140.20$344,394$189,413.75$315.0KVICI
10$32,664$1,186.18$966,234$607,376.13$933.6KVICI

MYOV vs VICI: Complete Analysis 2026

MYOVStock

Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, which is in Phase II clinical trial for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd.

Full MYOV Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this MYOV vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYOV vs SCHDMYOV vs JEPIMYOV vs OMYOV vs KOMYOV vs MAINMYOV vs NNNMYOV vs EPRTMYOV vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.